FDA Approves Second Drug to Prevent Influenza A and B

Drug Industry Daily
KEYWORDS FDA / Rx
A A

 The FDA has approved Relenza for prevention of flu in children ages 5 and older and adults, providing a second drug in addition to Tamiflu to prevent influenza A and B.

To View This Article:

Login

Subscribe To Drug Industry Daily